{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T14:03:40Z","timestamp":1648735420306},"reference-count":15,"publisher":"BMJ","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thorax"],"published-print":{"date-parts":[[1994,9,1]]},"DOI":"10.1136\/thx.49.9.920","type":"journal-article","created":{"date-parts":[[2008,12,13]],"date-time":"2008-12-13T03:22:59Z","timestamp":1229138579000},"page":"920-921","source":"Crossref","is-referenced-by-count":4,"title":["Atrial natriuretic peptide levels in the sleep apnoea\/hypopnoea syndrome."],"prefix":"10.1136","volume":"49","author":[{"given":"T W","family":"Mackay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M F","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Freestone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M R","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N J","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev.me.27.020176.002341","article-title":"The sleep apnea syndrome","volume":"2","author":"Guilleminault, C.; Tilkian, A.; Dement, W.C.","year":"1976","unstructured":"Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndrome. Annu Rev Med 1976;2:465-84.","journal-title":"Annu Rev Med"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/cs0740183","article-title":"Abnormal diurnal variation in salt and water excretion in patients with obstructive sleep apnoea","volume":"74","author":"Warley, A.R.H.; Stradling, JR","year":"1988","unstructured":"Warley ARH, Stradling JR. Abnormal diurnal variation in salt and water excretion in patients with obstructive sleep apnoea. Clin Sci 1988;74:183-5.","journal-title":"Clin Sci"},{"key":"ref_3","first-page":"659","article-title":"The clinical features of the sleep apnoea\/hypopnoea syndrome","volume":"72","author":"Whyte, K.F.; Allen, M.B.; Jeffrey, A.A.; Gould, G.A.; Douglas, N.J.","year":"1989","unstructured":"Whyte KF, Allen MB, Jeffrey AA, Gould GA, Douglas NJ. The clinical features of the sleep apnoea\/hypopnoea syndrome. Q JMed 1989;72:659-66.","journal-title":"Q JMed"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archinte.1988.00380060101020","article-title":"Renal function in patients with obstructive sleep apnea. Effect of nasal continuous positive airway pressure","volume":"148","author":"Krieger, J.; Imbs, J.L.; Schmidt, M.; Kurtz, D.","year":"1988","unstructured":"Krieger J, Imbs JL, Schmidt M, Kurtz D. Renal function in patients with obstructive sleep apnea. Effect of nasal continuous positive airway pressure. Arch Intern Med 1988; 148:1337-40.","journal-title":"Arch Intern Med"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1042\/cs0770407","article-title":"Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnoea before and during treatment with nasal continuous positive airway pressure","volume":"77","author":"Krieger, J.; Laks, L.; Wilcox, I.; Grunstein, R.R.; Costas, L.J.V.; McDougall, J.G.","year":"1989","unstructured":"Krieger J, Laks L, Wilcox I, Grunstein RR, Costas LJV, McDougall JG, et al. Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnoea before and during treatment with nasal continuous positive airway pressure. Clin Sci 1989;77:407-11.","journal-title":"Clin Sci"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1042\/cs0760031","article-title":"Urinary excretion of guanosine 3': 5'-cyclic monophosphate during sleep in obstructive sleep apnoea patients with and without nasal continuous positive airway pressure treatment","volume":"76","author":"Krieger, J.; Schmidt, M.; Sforza, E.; Lehr, L.; Imbs, J.L.; Coumaros, G.","year":"1989","unstructured":"Krieger J, Schmidt M, Sforza E, Lehr L, Imbs JL, Coumaros G, et al. Urinary excretion of guanosine 3':5'-cyclic monophosphate during sleep in obstructive sleep apnoea patients with and without nasal continuous positive airway pressure treatment. Clin Sci 1989;76:31-7.","journal-title":"Clin Sci"},{"key":"ref_7","first-page":"443","article-title":"Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea","volume":"40","author":"Krieger, J.; Follenius, M.; Sforza, E.; Brandenberger, G.; Peter, J.D.","year":"1991","unstructured":"Krieger J, Follenius M, Sforza E, Brandenberger G, Peter JD. Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea. Clin Sci 1991;40:443-9.","journal-title":"Clin Sci"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/07853899109148039","article-title":"Atrial natriuretic peptide in habitual snorers","volume":"23","author":"true","year":"1991","unstructured":"Partinen M, Telakivi T, Kaukiainen A, Salmi T, Farkkila M, Saijonmaa 0, et al. Atrial natriuretic peptide in habitual snorers. Ann Med 1991;23:147-51.","journal-title":"Ann Med"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0140-6736(92)91660-Z","article-title":"Clinical value of polysomnography","volume":"339","author":"Douglas, N.J.; Thomas, S.; Jan, M.A.","year":"1992","unstructured":"Douglas NJ, Thomas S, Jan MA. Clinical value of polysomnography. Lancet 1992;339:347-50.","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archinte.1992.00400150068012","article-title":"Factors inpairing daytime performance in patients with the sleep apnoea\/hypopnoea syndrome","volume":"152","author":"Cheshire, K.; Engleman, H.; Deary, I.; Douglas, N.J.","year":"1992","unstructured":"Cheshire K, Engleman H, Deary I, Douglas NJ. Factors inpairing daytime performance in patients with the sleep apnoea\/hypopnoea syndrome. Arch Intern Med 1992;152: 538-41.","journal-title":"Arch Intern Med"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1042\/cs0780371","article-title":"Effect of lithium on the renal actions of a-human atrial natriuretic peptide in normal man","volume":"78","author":"Freestone, S.; Jeffrey, R.F.; Bonner, C.V.; Lee, M.R.","year":"1990","unstructured":"Freestone S, Jeffrey RF, Bonner CV, Lee MR. Effect of lithium on the renal actions of a-human atrial natriuretic peptide in normal man. Clin Sci 1990;78:371-5.","journal-title":"Clin Sci"},{"key":"ref_12","first-page":"1349","article-title":"Application of a radioimmunoassay for angiotensin I to the physiologic measurement of plasma renin activity in normal human subjects. _7 Clin Endocrinol Metab","volume":"29","author":"Haber, E.; Koerner, T.; Page, L.B.; Kliman, B.; Purnode, A.","year":"1969","unstructured":"Haber E, Koerner T, Page LB, Kliman B, Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurement of plasma renin activity in normal human subjects. _7 Clin Endocrinol Metab 1969;29: 1349-55."},{"key":"ref_13","first-page":"326","article-title":"The distribution of dopamine and dopa in various animals and a method for their determination and diverse biological material. _7 Phannacol Exp Ther","volume":"145","author":"Anton, A.H.; Sayre, D.F.","year":"1964","unstructured":"Anton AH, Sayre DF. The distribution of dopamine and dopa in various animals and a method for their determination and diverse biological material. _7 Phannacol Exp Ther 1964;145:326-36."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/sleep\/14.1.83","article-title":"Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome","volume":"14","author":"Baruzzi, A.; Riva, R.; Cirignotta, F.; Zucconi, M.; Cappelli, M.; Lugaresi, E.","year":"1991","unstructured":"Baruzzi A, Riva R, Cirignotta F, Zucconi M, Cappelli M, Lugaresi E. Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome. Sleep 1991;14:83-6.","journal-title":"Sleep"},{"key":"ref_15","first-page":"37","article-title":"Plasma levels of atrial natriuretic peptide (ANP) in obstructive sleep apnoea (OSA). Thorax 1988; 43: 253P","volume":"16","author":"Warley, A.R.H.; Morice, A.; Stradling, JR","year":"1993","unstructured":"Warley ARH, Morice A, Stradling JR. Plasma levels of atrial natriuretic peptide (ANP) in obstructive sleep apnoea (OSA). Thorax 1988;43:253P. 16 Lin C-C, Tsan K-W, Lin C-Y. Plasma levels of atrial natriuretic factor in moderate to severe obstructive sleep apnea syndrome. Sleep 1993;16:37-9.","journal-title":"Sleep; Plasma levels of atrial natriuretic factor in moderate to severe obstructive sleep apnea syndrome"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thx.49.9.920","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T09:20:14Z","timestamp":1601112014000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thx.49.9.920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,9,1]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1994,9,1]]}},"URL":"https:\/\/doi.org\/10.1136\/thx.49.9.920","relation":{},"ISSN":["0040-6376"],"issn-type":[{"value":"0040-6376","type":"print"}],"subject":[],"published":{"date-parts":[[1994,9,1]]}}}